Labcorp to speak at the Credit Suisse 31st Annual Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 31, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Credit Suisse 31st Annual Healthcare Conference on Tuesday, Nov. 8 , at 1:25 p.m.

Labcorp announces 2022 third quarter results

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 27, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022 , and updated full-year guidance.

Labcorp appoints Google Cloud executive Kirsten Kliphouse to its Board of Directors

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 13, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Kirsten Kliphouse , president of Americas , Google Cloud, has joined its Board of Directors as an independent member. This press release features multimedia.

Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 12, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on Dec. 9, 2022, to stockholders of record as of the close of business on Nov. 17, 2022.

Labcorp establishes comprehensive laboratory relationship with Ascension

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 3, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the completion of transactions that establish a long-term laboratory relationship with Ascension, one of the leading non-profit and Catholic health systems in the United States.

Labcorp Drug Development selects Dr. Deepa Desai as country head for India

BURLINGTON, N.C., Oct. 3, 2022 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Deepa Desai as senior vice president and country head of Labcorp Drug Development India. 

Labcorp to announce third quarter financial results on October 27, 2022

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 27, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. 27, 2022 . The company will host a conference call and webcast beginning at 9

Tumor inflammation, obesity, and proliferative status as biomarkers in gastroesophageal adenocarcinoma

Mutational landscape and clinical characterization of over 17000 patient samples with myeloid malignancies using real world data

Comprehensive genomic and immune profiling defines immunotherapy treatment in NSCLC patients with low PD L1 IHC